"Instituut Verbeeten levert zorg op het gebied van radiotherapie en nucleaire geneeskunde. We leveren hoogwaardige kwaliteit als het gaat om deskundigheid en zorg voor patiënten én hebben een optimale samenwerking met andere instellingen. We bieden zorg op maat, met aandacht voor wat de patiënt zelf belangrijk of nodig vindt."

During the past decade, Dr. Bernard Verbeeten Instituut conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr. Bernard Verbeeten Instituut" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 15 trials, followed by "Maastricht Radiation Oncology" with 2 trials sponsored, "The Netherlands Cancer Institute" with 2 trials sponsored, "Leiden University Medical Center" with 1 trials sponsored and "Navotek Medical, Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Bernard Verbeeten Instituut" #1 collaborator was "Dutch Cancer Society" with 3 trials as a collaborator, "British Medical Research Council" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator and "Grupo Oncologico Cooperativo Chileno de Investigation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Bernard Verbeeten Instituut" are "Brain and Central Nervous System Tumors" (4 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Dr. Bernard Verbeeten Instituut" in a lesser frequency.

Most popular intervention types in "Dr. Bernard Verbeeten Instituut" are "Radiation" (21 trials), "Drug" (12 trials), "Procedure" (5 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "cisplatin" (3 trials), "fluorouracil" (3 trials), "adjuvant therapy" (2 trials) and "conventional surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Bernard Verbeeten Instituut" are 17 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Dr. Bernard Verbeeten Instituut". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Dr. Bernard Verbeeten Instituut, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Bernard Verbeeten Instituut, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".